85
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Influence of water uptake, gel network, and disintegration time on prednisone release from encapsulated solid dispersions

&
Pages 184-191 | Received 06 Mar 2009, Accepted 29 May 2009, Published online: 10 Mar 2010

References

  • Leuner C, Dressman JB. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60.
  • Serajuddin ATM. Solid dispersion of poorly water soluble drugs: Early promises, subsequent problems and recent breakthroughs. J Pharm Sci 1999;88:1058–1066.
  • de Waard H, Hinrichs WLJ, Visser MR. Bologna C, Frijlink HW. Unexpected differences in dissolution behaviour of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm 2008;349:66–73.
  • Jones BE. Two-piece gelatin capsules: Excipients for powder products, European practice. Pharm Technol Eur 1995;7:25–34.
  • Botzolakis JE, Augsburger LL. Disintegrating agents in hard gelatin capsules. Part I: Mechanism of action. Drug Dev Ind Pharm 1998;14:29–41.
  • Gohel MC, Patel LD. Improvement of nimesulide dissolution from solid dispersions containing croscarmellose sodium and aerosil 200. Acta Pharm 2002;52:227–241.
  • Desai DS, Rubitski BA, Varia SA, Newman AW. Physical interactions of magnesium stearate with starch-derived disintegrants and their effects on capsule and tablet dissolution. Int J Pharm 1993;91:217–226.
  • Bolhuis GK, Zuurman K, te Wierik GHP. Improvement of dissolution of poorly soluble drugs by solid deposition on a super disintegrant. II. The choice of super disintegrants and effect of granulation. Eur J Pharm Biopharm 1997;5:63–69.
  • Sjökvist E. Nyström C, Aldén M. Physicochemical aspects of drug release. IX. Investigation of some factors that impair dissolution of drugs from solid particulate dispersion systems. Int J Pharm 1998;54:161–170.
  • Tischner D, Reichardt HM. Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol 2007;275:62–70.
  • Levine AM, Tulpule A, Espina B, Sherrod A, Boswell WD, Lieberman RD, Nathwani BN, Welles L. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed aids related non-Hodgkin’s lymphoma: Results of therapy and correlates of response. J Clin Oncol 2004;22:2662–2670.
  • Mccomsey CA, Whalen CC, Mawhorter D, Asaad R, Valdez H, Patki AH, Klaumunzner J, Gopalakrishna KV, Calabrese LH, Lederman MM. Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS 2001;15:321–327.
  • Becker JM, Arora A, Scarfone RJ, Spector ND, Fontana-Penn ME, Gracely E, Joffe MD, Goldsmith DP, Malatack JJ. Oral versus intravenous corticosteroids in children hospitalized with asthma. J Allergy Clin Immunol 1999;103:586–590.
  • Hutto CJ, Bratton TH. Palatability and cost comparison of five liquid corticosteroid formulations. J Pediatr Oncol Nurs 1999;16:74–77.
  • Mitchell JC, Counselman FL. A taste comparison of three different liquid steroid preparations: Prednisone, prednisolone, and dexamethasone. Acad Emerg Med 2003;10:400–403.
  • Barnett PLG, Caputo GL, Baskin M, Kupperman N. Intravenous versus oral corticosteroids in the management of acute asthma in children. Ann Emerg Med 1997;29:212–217.
  • Ferrari F, Bertoni M, Bonferoni C, Rossi S, Caramella C, Bolhius G. Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: Optimization with a simple lattice design. Pharm Dev Technol 1996;1:159–164.
  • Giovagnoli S, Blasi P, Ricci M, Schoubben A, Perioli L, Rossi C. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation. J Pharm Sci 2008;97:303–317.
  • özkan Y, Doğanay N, Dikmen N, Işimer A. Enhanced release of solid dispersions of etodolac in polyethylene glycol. Il Fármaco 2000;55:433–438.
  • Gohil UC, Podczeck F, Turnbull N. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules. Int J Pharm 2004;285:51–63.
  • Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients. 4th ed. London: Pharmaceutical Press/Washington, DC: American Pharmaceutical Association; 2003.
  • Allen LV, Levinson RS, Martono DD. Dissolution rates of hydrocortisone and prednisone utilizing sugar solid dispersion systems in tablet form. J Pharm Sci 1978;67:979–981.
  • Lin CW, Cham TM. Effect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions. Int J Pharm 1996;127:261–272.
  • Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga U, Ohike A, Ibuki R, Higaki K, Kimura T. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J Control Release 2005;108:86–395.
  • Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS Pharm SciTech 2006;7: Art. 55.
  • te Wierik GHP, Eissens AC, Bergsma J, Arends-Scholte AW, Bolhuis GK. A new generation starch product as excipient in pharmaceutical tablets III. Parameters affecting controlled drug release from tablets based on high surface area retrograded pregelatinized potato starch. Int J Pharm 1997;157:181–187.
  • Li H, Gu X. Correlation between drug dissolution and polymer hydration: A study using texture analysis. Int J Pharm 2007;342:18–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.